Deccan Health Care Ltd
Incorporated in 1996, Deccan Healthcare Ltd is a manufacturer of Fast moving consumer health products[1]
- Market Cap ₹ 47.7 Cr.
- Current Price ₹ 20.4
- High / Low ₹ 39.1 / 16.0
- Stock P/E 41.1
- Book Value ₹ 45.4
- Dividend Yield 0.00 %
- ROCE 1.65 %
- ROE 1.14 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.45 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 19.5%
- Company has a low return on equity of 1.10% over last 3 years.
- Contingent liabilities of Rs.16.8 Cr.
- Promoter holding has decreased over last 3 years: -8.14%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
42.24 | 33.78 | 33.17 | 45.02 | 59.73 | 75.06 | |
30.57 | 31.74 | 27.54 | 43.06 | 55.97 | 71.92 | |
Operating Profit | 11.67 | 2.04 | 5.63 | 1.96 | 3.76 | 3.14 |
OPM % | 27.63% | 6.04% | 16.97% | 4.35% | 6.29% | 4.18% |
0.06 | 0.06 | -3.46 | 0.02 | 0.01 | 0.01 | |
Interest | 0.18 | 0.11 | 0.15 | 0.11 | 0.09 | 0.07 |
Depreciation | 1.42 | 1.47 | 1.47 | 1.43 | 1.47 | 1.45 |
Profit before tax | 10.13 | 0.52 | 0.55 | 0.44 | 2.21 | 1.63 |
Tax % | 0.39% | 25.00% | 40.00% | 31.82% | 33.03% | 28.83% |
10.09 | 0.39 | 0.32 | 0.31 | 1.49 | 1.16 | |
EPS in Rs | 6.42 | 0.25 | 0.20 | 0.18 | 0.73 | 0.50 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 12% |
3 Years: | 31% |
TTM: | 26% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | -35% |
3 Years: | -20% |
TTM: | -22% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | -12% |
3 Years: | -13% |
1 Year: | -45% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 1% |
3 Years: | 1% |
Last Year: | 1% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
Equity Capital | 15.71 | 15.71 | 15.71 | 17.04 | 20.38 | 23.43 |
Reserves | 60.52 | 60.91 | 61.23 | 64.52 | 76.53 | 82.97 |
0.87 | 1.03 | 1.25 | 1.61 | 1.90 | 1.14 | |
15.89 | 14.61 | 12.44 | 13.62 | 9.24 | 17.39 | |
Total Liabilities | 92.99 | 92.26 | 90.63 | 96.79 | 108.05 | 124.93 |
21.25 | 19.87 | 18.53 | 16.85 | 15.69 | 14.38 | |
CWIP | 0.00 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 37.90 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
33.84 | 72.32 | 72.10 | 79.94 | 92.36 | 110.55 | |
Total Assets | 92.99 | 92.26 | 90.63 | 96.79 | 108.05 | 124.93 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
2.68 | 0.22 | -0.57 | -6.76 | -12.55 | -6.43 | |
-1.94 | -0.07 | -0.05 | 0.27 | -0.30 | -0.14 | |
-1.77 | -0.37 | 0.07 | 5.26 | 14.04 | 7.52 | |
Net Cash Flow | -1.03 | -0.22 | -0.56 | -1.23 | 1.19 | 0.95 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
Debtor Days | 177.66 | 134.74 | 141.07 | 97.21 | 60.44 | 60.98 |
Inventory Days | 0.00 | 890.81 | 1,182.75 | 683.64 | 445.05 | 327.35 |
Days Payable | 112.09 | 147.78 | 123.28 | 41.68 | 69.00 | |
Cash Conversion Cycle | 177.66 | 913.46 | 1,176.04 | 657.58 | 463.81 | 319.32 |
Working Capital Days | 421.77 | 545.99 | 603.01 | 509.48 | 478.54 | 424.28 |
ROCE % | 0.81% | 5.62% | 0.68% | 2.53% | 1.65% |
Documents
Announcements
-
Board Meeting Intimation for Appointment Of Company Secretary And Compliance Officer
2d - Board meeting on July 4 to approve appointment of Company Secretary and Compliance Officer.
- Closure of Trading Window 25 Jun
- Extra - Ordinary General Meeting - Schedule Of EGM 16 Jun
- Intimation Of Book Closure For The Extra Ordinary General Meeting 16 Jun
-
Extra - Ordinary General Meeting Of The Members Of The Company To Be Held On 09Th July 2025 At 3:30 PM
16 Jun - EGM on July 9, 2025 to appoint Mr. Mohak Gupta as Executive Director for five years.
Business Overview:[1]
DHL is a Nutraceutical and wellness product company. Its food pills and meals are categorized under Fast Moving Consumer Healthcare (FMCH) products and covers 52 consumer wellness goals preventing over 200 diseases, disorders and disabilities due to micro nutritional deficiency. Company does sales of its Be Young brand through e-commerce platform www.beyoungstore.com